DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain – suggesting an apoptotic cell death

British Journal of Cancer

Volumn 71, Issue 4, 1995, Pages 717-720

  Vallbol, C ^a   Bergenheim, T ^a   Bergh, A ^a   Grankvist, K ^a   Henriksson, R ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Chemotherapy; DNA; Estramustine; Glioma

Indexed keywords

AGAROSE; ANTIMITOTIC AGENT; DNA FRAGMENT; ESTRAMUSTINE; NUCLEOTIDE; OXYGEN RADICAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN TISSUE; CELL CYCLE G2 PHASE; CELL DAMAGE; CELL DEATH; CELL MEMBRANE; CONTROLLED STUDY; DNA DETERMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; GLIOBLASTOMA; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MITOSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; APOPTOSIS; BRAIN; BRAIN NEOPLASMS; COMPARATIVE STUDY; DNA; DNA DAMAGE; DNA, NEOPLASM; ELECTROPHORESIS, AGAR GEL; ESTRAMUSTINE; GLIOMA; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T;

EID: 0028930051     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1995.140     Document Type: Article

References (29)

1. BERGENHEIM AT, ZACKRISSON B, ELFVERSSON J AND HENRIKS-SON R. (1993a). Synergism between estramustine and radiotherapy in a rat glioma model. J. Neuro-Oncol., 15 (Suppl.), S3.
2. BERGENHEIM AT, GUNNARSSON PO, EDMAN K, VON SCHOULTZ E, HARIZ MI AND HENRIKSSON R. (1996). Uptake and retention of estramustine and the presence of estramustine-binding protein in malignant brain tumors in humans. Br. J. Cancer, 67, 358–361.
3. BERGENHEIM AT, ELFVERSON J, GUNNARSSON, P-O, EDMAN K, HARTMAN M AND HENRIKSSON R. (1994). Cytotoxic effect and uptake of estramustine in a rat glioma model. Int. J. Oncol., 5, 293–299.
4. BJERMER L, VON SCHOULTZ E, NORBERG B AND HENRIKSSON R. (1988). Estramustine inhibits monocyte phagocytosis. Prostate, 13, 49–55.
5. DAHLLOF B, BILLSTROM A, CABRAL F AND HARTLEY-ASP B. (1993). Estramustine depolymerizes microtubules by binding to tubulin. Cancer Res., 53, 4573–4581.
6. DIVE C AND WYLLIE AH. (1993). Apoptosis and cancer chemotherapy. In Frontiers in Pharmacology: Cancer Chemotherapy, Hickman JA and Tritton TT. (eds) pp. 21-26. Blackwell Scientific Publications: Oxford.
7. EKLOV S, NILSSON S AND LARSSON A. (1992). Evidence for a non-estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivo. Prostate, 30, 43–50.
8. ENGSTROM KG, GRANKVIST K AND HENRIKSSON R. (1991). Early morphological detection of estramustine cytotoxicity measured as alteration in cell size and shape by a new technique of micro- perifusion. Eur. J. Cancer, 10, 1288–1295.
9. GAVRIELI Y, SHERMAN Y AND BEN-SASSON SA. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol., 119, 493–501.
10. GORCYZA W, GONG JP AND DARZYNKIEWICZ Z. (1993). Detection of DNA strand breaks in invididual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res., 53, 1945–1951.
11. HARTLEY-ASP B. (1984). Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3. Prostate 5, 93–100.
12. HARTLEY-ASP B AND KRUSE E. (1986). Nuclear protein matrix as a target for estramustine-induced cell death. Prostate, 9, 387-392
13. HENRIKSSON R, BJERMER L, VON SCHOULTZ E AND GRANKVIST K. (1990). The effect of estramustine on microtubule is different from the direct action via oxygen radicals on DNA and cell membrane. Anticancer Res., 10, 303–310.
14. HOCKENBERY DM, OLTVAI ZN, YIN X-M, MILLIMAN CL AND KORSMEYER SJ. (1993). Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75, 241–251.
15. ISAACS JT. (1994). Advances and controversies in the study of programmed cell death/apoptosis in the development of and therapy for cancer. Curr. Opin. Oncol., 6, 82–89.
16. MURPHY GP, SLACK NH AND MITTELMAN A. (1984). Use of estramustine phosphate in prostate cancer by the national prostatic cancer project and by Roswell Park Memorial Institute. Urology, 23 (Suppl.), 54.
17. NORONHA-DUTRA AA, STEEN-DUTRA EM AND WOOLF N. (1988). Epinephrine-induced cytotoxicity of rat plasma. Its effects on isolated cardiac myocytes. Lab. Invest., 6, 817–823.
18. NOSEDA A, WHITE JG, GODWIN PL, JEROME WG AND MODEST EJ. (1989). Membrane damage in leukemic cells induced by ether and ester lipids: an electron microscopic study. Exp. Mol. Pathol., 1, 69–83.
19. PIENTA KJ AND LEHR JE. (1993). Inhibition of prostate cancer growth by estramustine and etoposide: evidence for interaction at the nuclear matrix. J. Urol., 149, 1622–1625.
20. PIEPMEIER JM, KEEFE DL, WEINSTEIN MA, YOSHIDA D, ZIELINSKI J, LIN TT, CHEN Z AND NAFTOLIN F. (1993). Estramustine and estrone analogs rapidly and reversibly inhibit deoxyribonucleic acid synthesis and alter morphology in cultured human glioblastoma cells. Neurosurgery, 32, 422–431.
21. SANDSTROM P-E, JONSSON O, GRANKVIST K AND HENRIKSSON R. (1994). Identification of potassium flux pathways and their role in the cytotoxicity of estramustine in human malignant glioma-, prostatic carinoma-, and pulmonary carcinoma-cell lines. Eur. J. Cancer (in press).
22. VON SCHOULTZ E, LUNDBLAD D, BERGH J, GRANKVIST K AND HENRIKSSON R. (1988). Estramustine binding protein and antiproliferative effect of estramustine in human glioma cell lines. Br. J. Cancer, 58, 326–329.
23. VON SCHOULTZ E, GRANKVIST K, GUSTAFSSON H AND HENRIKSSON R. (1991). Effects of estramustine on DNA and cell membrane in malignant glioma cells. Acta Oncol., 30, 719–723.
24. STEARNS ME, WANG M, TEW KD AND BINDER LI. (1988). Estramustine binds a MAP-1 like protein to inhibit microtubule assembly in vitro and disrupt microtubule organisation in DU 145 cells. J. Cell. Biol., 107, 2647–2656.
25. TEW KD AND STEARNS ME. (1987). Hormone-independent, nonalkylating mechanism of cytotoxicity for estramustine. Urol. Res., 15, 155–159.
26. TEW KD, ERIKSSON LC, WHITE G, WANG A, SHEIN PS AND HARTLEYASP B. (1983). Cytotoxicity of a steroid-nitrogen mustard derivative through non-DNA targets. Mol. Pharmacol., 24, 324–328.
27. TOUNEKTI O, PRON G, BELEHRADEK JR J AND MIR LM. (1993). Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res., 53, 5462–5469.
28. WIJSMAN JH, JONKER RR, KEIJZER R, DEVELDE DJH, CORNEL- ISSE CJ AND VAN DIERENDONCK JH. (1993). A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA. J. Histochem. Cytochem., 41, 7–12.
29. YOSHIDA D, CORNELL-BELL A AND PIEPMEIER J. (1994). Selective antimitotic effects of estramustine correlate with its antimicrotubule properties on glioblastoma and astrocytes. Neurosurgery, 34, 863–868.